Management of chemotherapy hypersensitivity reactions and desensitization: An SGO clinical practice statement.

Hall, T R; MacDonald, J E; Bylinowski, K M; Alvarez, E A; Hardesty, M M; Smith, J A

Hall, T R; MacDonald, J E; Bylinowski, K M; Alvarez, E A; Hardesty, M M; Smith, J A.

Afiliación

Hall TR; Baylor College of Medicine, Houston, TX, United States of America. Electronic address: Tracilyn.hall@bcm.edu.
MacDonald JE; Medical University of South Carolina, Charleston, SC, United States of America.
Bylinowski KM; University of Pittsburgh Medical Center, Pittsburgh, PA, United States of America.
Alvarez EA; University of California - San Francisco, San Francisco, CA, United States of America.
Hardesty MM; Alaska Women's Cancer Care, Anchorage, AK, United States of America.
Smith JA; UT Health McGovern Medical School, Houston, TX, United States of America.

Gynecol Oncol ; 177: 180-185, 2023 Oct.

Article en En | MEDLINE | ID: mdl-37717346

Palabras clave

Carboplatin; Chemotherapy; Desensitization; Hypersensitivity; Taxanes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Gynecol Oncol Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google